| 000 | 018360000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025508.0 | ||
| 008 | 081025s2008 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.04.Ph.D.2008.Eh.C | ||
| 100 | 0 | _aEhab Mosaad Abdelghany | |
| 245 | 1 | 0 |
_aComparative study between classic CHOP and CHOP+VP16 in treatment of diffse large cell NHL / _cEhab Mosaad Abdelghany ; Supervised Hussein M.Khaled , Ahmed Abdelwarith , Abdrahman N.Zekry |
| 246 | 1 | 5 | _aدراسة مقارنة بين العلاج الكيميائى اندوكسان+الكوفين+ادرياميسين+هوستاكورتين مع او بدون اضافة الفيبسيد في علاج حالات سرطان الغدد الليمفاوية |
| 260 |
_aCairo : _bEhab Mosaad Abdelghany , _c2008 |
||
| 300 |
_a154P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department Of Oncology | ||
| 520 | _aDiffuse large B - cell lymphoma (DLBCL) is the most common subtype of non - hodgkin's lymphoma (NHL) .Patients with aggressive (DLBCL) at time of diagnosis were reported to have a poor prognosis with standard therapy.Addition of other active chemotherapeutic drugs as ETOPOSIDE to the classic chemotherapy (CHOP) has been studied as a way of improving the clinical outcomes in DLBCL patients | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBel - 6 | |
| 653 | 4 | _aCHEOP | |
| 653 | 4 | _aDiffuse large cell lymphoma | |
| 700 | 0 |
_aAbdrahman N.Zekry , _eSupervisor |
|
| 700 | 0 |
_aAhmed Abdelwarith , _eSupervisor |
|
| 700 | 0 |
_aHussein M.Khaled , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c14282 _d14282 |
||